Conclusion Is NAD glutathione
Most patients notice appetite reduction within the first few weeks as the dose ramps up, with cravings quieting and eating patterns shifting over the second and third months
In pre-clinical research, it is primarily studied for its effects on gastrointestinal healing, tendon and ligament repair, vascular growth (angiogenesis), and potential neuroprotective properties
Transition Plan: Depending on your circumstances, your provider may recommend a direct switch or a gradual tapering off of semaglutide while starting tirzepatide
In 2024 semaglutide (Wegovy) became the first weight loss drug to also be approved for the reduction of risk of serious cardiovascular events in patients with cardiovascular disease and obesity or overweight
Many patients exploring GLP-1 therapy wonder whether stacking Mounjaro and semaglutide could accelerate weight loss results